Ifeanyi Uzochukwu, David Moyes, Gordon Proctor, Mark Ide
{"title":"坏疽性坏疽病生态失调的关键因素对病因学研究的系统回顾。","authors":"Ifeanyi Uzochukwu, David Moyes, Gordon Proctor, Mark Ide","doi":"10.3389/froh.2023.1095858","DOIUrl":null,"url":null,"abstract":"<p><p>Noma is a rapidly progressing periodontal disease with up to 90% mortality in developing countries. Poor, immunocompromised and severely malnourished children (2 to 6 years old) are mostly affected by Noma. Prevention and effective management of Noma is hindered by the lack of sufficient cohesive studies on the microbial etiology of the disease. Research efforts have not provided a comprehensive unified story of the disease. Bridging the gap between existing studies gives an insight on the disease pathogenesis. This current systematic review of etiological studies focuses on the key players of dysbiosis in Noma disease. This review was performed in accordance with the Preferred Reporting Items for Systemic review and Meta-Analyses (PRISMA) statement. Web of Science, MEDLINE <i>via</i> PubMed, Cochrane Library, Scopus, and Science Direct were searched electronically for clinical trials which applied culture dependent or molecular techniques to identify oral microbiota from Noma patients. Trials which involved periodontal diseases except Noma were excluded. After screening 275 articles, 153 full-texts articles were assessed for eligibility of which eight full text articles were selected for data extraction and analysis. The results show that 308 samples from 169 Noma participants (6 months to 15 years old) have been used in clinical trials. There was some variance in the microbiome identified due to the use of 3 different types of samples (crevicular fluid, subgingival plaque, and swabbed pus) and the ambiguity of the stage or advancement of Noma in the studies. Other limitations of the studies included in this review were: the absence of age-matched controls in some studies; the constraints of colony morphology as a tool in distinguishing between virulent fusobacterium genus at the species level; the difficulty in culturing spirochaetes in the laboratory; the choice of primers in DNA amplification; and the selection of probe sets in gene sequencing. This systematic review highlights spirochaetes and P. intermedia as putative trigger organisms in Noma dysbiosis, shows that F. nucleatum promotes biofilms formation in late stages of the disease and suggests that future studies should be longitudinal, with high throughput genome sequencing techniques used with gingival plaque samples from early stages of Noma.</p>","PeriodicalId":12463,"journal":{"name":"Frontiers in Oral Health","volume":"4 ","pages":"1095858"},"PeriodicalIF":0.0000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10020349/pdf/","citationCount":"1","resultStr":"{\"title\":\"The key players of dysbiosis in Noma disease; A systematic review of etiological studies.\",\"authors\":\"Ifeanyi Uzochukwu, David Moyes, Gordon Proctor, Mark Ide\",\"doi\":\"10.3389/froh.2023.1095858\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Noma is a rapidly progressing periodontal disease with up to 90% mortality in developing countries. Poor, immunocompromised and severely malnourished children (2 to 6 years old) are mostly affected by Noma. Prevention and effective management of Noma is hindered by the lack of sufficient cohesive studies on the microbial etiology of the disease. Research efforts have not provided a comprehensive unified story of the disease. Bridging the gap between existing studies gives an insight on the disease pathogenesis. This current systematic review of etiological studies focuses on the key players of dysbiosis in Noma disease. This review was performed in accordance with the Preferred Reporting Items for Systemic review and Meta-Analyses (PRISMA) statement. Web of Science, MEDLINE <i>via</i> PubMed, Cochrane Library, Scopus, and Science Direct were searched electronically for clinical trials which applied culture dependent or molecular techniques to identify oral microbiota from Noma patients. Trials which involved periodontal diseases except Noma were excluded. After screening 275 articles, 153 full-texts articles were assessed for eligibility of which eight full text articles were selected for data extraction and analysis. The results show that 308 samples from 169 Noma participants (6 months to 15 years old) have been used in clinical trials. There was some variance in the microbiome identified due to the use of 3 different types of samples (crevicular fluid, subgingival plaque, and swabbed pus) and the ambiguity of the stage or advancement of Noma in the studies. Other limitations of the studies included in this review were: the absence of age-matched controls in some studies; the constraints of colony morphology as a tool in distinguishing between virulent fusobacterium genus at the species level; the difficulty in culturing spirochaetes in the laboratory; the choice of primers in DNA amplification; and the selection of probe sets in gene sequencing. This systematic review highlights spirochaetes and P. intermedia as putative trigger organisms in Noma dysbiosis, shows that F. nucleatum promotes biofilms formation in late stages of the disease and suggests that future studies should be longitudinal, with high throughput genome sequencing techniques used with gingival plaque samples from early stages of Noma.</p>\",\"PeriodicalId\":12463,\"journal\":{\"name\":\"Frontiers in Oral Health\",\"volume\":\"4 \",\"pages\":\"1095858\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10020349/pdf/\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Frontiers in Oral Health\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.3389/froh.2023.1095858\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Oral Health","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3389/froh.2023.1095858","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1
摘要
坏疽性口炎是一种进展迅速的牙周病,在发展中国家死亡率高达90%。贫穷、免疫功能低下和严重营养不良的儿童(2至6岁)主要受到坏疽性口炎的影响。对坏疽性口炎的微生物病因缺乏足够的凝聚力研究,阻碍了坏疽性口炎的预防和有效管理。研究工作还没有提供一个关于这种疾病的全面统一的故事。弥合现有研究之间的差距,使人们对疾病的发病机制有了深入的了解。本系统综述的病因学研究集中在坏疽性坏疽病中生态失调的关键因素。本综述按照系统评价和荟萃分析的首选报告项目(PRISMA)声明进行。通过电子检索Web of Science、MEDLINE via PubMed、Cochrane Library、Scopus和Science Direct,寻找应用培养依赖或分子技术鉴定野口炎患者口腔微生物群的临床试验。除坏疽性口炎外涉及牙周病的试验被排除在外。在对275篇文章进行筛选后,对153篇全文文章进行合格性评估,从中选择8篇全文文章进行数据提取和分析。结果显示,来自169名Noma参与者(6个月至15岁)的308份样本已用于临床试验。由于使用了3种不同类型的样本(沟液、龈下菌斑和拭子脓液),以及研究中坏疽性口炎的分期或进展不明确,所鉴定的微生物组存在一些差异。本综述纳入的研究的其他局限性包括:一些研究缺乏年龄匹配的对照;菌落形态在种水平上作为区分强毒梭杆菌属的工具的限制实验室培养螺旋体的困难;DNA扩增引物的选择;以及基因测序中探针组的选择。这篇系统综述强调了螺旋体和中间芽胞杆菌可能是坏疽性口炎失调的触发生物,表明核梭菌在疾病晚期促进生物膜的形成,并建议未来的研究应该是纵向的,使用高通量基因组测序技术对坏疽性口炎早期的牙龈斑块样本进行研究。
The key players of dysbiosis in Noma disease; A systematic review of etiological studies.
Noma is a rapidly progressing periodontal disease with up to 90% mortality in developing countries. Poor, immunocompromised and severely malnourished children (2 to 6 years old) are mostly affected by Noma. Prevention and effective management of Noma is hindered by the lack of sufficient cohesive studies on the microbial etiology of the disease. Research efforts have not provided a comprehensive unified story of the disease. Bridging the gap between existing studies gives an insight on the disease pathogenesis. This current systematic review of etiological studies focuses on the key players of dysbiosis in Noma disease. This review was performed in accordance with the Preferred Reporting Items for Systemic review and Meta-Analyses (PRISMA) statement. Web of Science, MEDLINE via PubMed, Cochrane Library, Scopus, and Science Direct were searched electronically for clinical trials which applied culture dependent or molecular techniques to identify oral microbiota from Noma patients. Trials which involved periodontal diseases except Noma were excluded. After screening 275 articles, 153 full-texts articles were assessed for eligibility of which eight full text articles were selected for data extraction and analysis. The results show that 308 samples from 169 Noma participants (6 months to 15 years old) have been used in clinical trials. There was some variance in the microbiome identified due to the use of 3 different types of samples (crevicular fluid, subgingival plaque, and swabbed pus) and the ambiguity of the stage or advancement of Noma in the studies. Other limitations of the studies included in this review were: the absence of age-matched controls in some studies; the constraints of colony morphology as a tool in distinguishing between virulent fusobacterium genus at the species level; the difficulty in culturing spirochaetes in the laboratory; the choice of primers in DNA amplification; and the selection of probe sets in gene sequencing. This systematic review highlights spirochaetes and P. intermedia as putative trigger organisms in Noma dysbiosis, shows that F. nucleatum promotes biofilms formation in late stages of the disease and suggests that future studies should be longitudinal, with high throughput genome sequencing techniques used with gingival plaque samples from early stages of Noma.